88
Views
1
CrossRef citations to date
0
Altmetric
Perspective

Radical cystectomy: do we need standardization?

, , , , &
Pages 101-107 | Received 14 Aug 2016, Accepted 08 Dec 2016, Published online: 28 Dec 2016

References

  • Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403.
  • Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–653.
  • Stenzl A, Cowan NC, De Santis M, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011;59(6):1009–1018.
  • Department of Health and Human Service. Annual Cancer Statistic Review: including cancer trends. Bethesda (MD): National Institutes of Health, NCI; 1987. p. 1950–1985.
  • Mahdavifar N, Ghoncheh M, Pakzad R, et al. Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev. 2016;17(1):381–386.
  • Murphy LJT, Desnos E. The history of urology. Springfield, Ill.: Thomas; 1972. p. xiii, 531.
  • Jewett HJ, Lewis EL. Infiltrating carcinoma of the bladder; curability by total cystectomy. J Urol. 1948;60(1):107–118.
  • Marshall VJ, Whitemore WF Jr. A technique for the extension of radical surgery in the treatment of vesical cancer. Cancer. 1949;2(3):424–428.
  • Willet FW Jr, M.D. Bladder cancer. CA-Cancer J Clini. 1978;28(3):170–177.
  • Hendry WF. Morbidity and mortality of radical cystectomy (1971-78 and 1978-85). J R Soc Med. 1986;79(7):395–400.
  • Stimson CJ, Chang SS, Barocas DA, et al. Early and late perioperative outcomes following radical cystectomy: 90-day related mortality in a contemporary series. J Urol. 2010;184(4):1296–1300.
  • Witjes A, Lebret T, Comperat E. Updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2016:1-14. pii S0302–2838(16)30290-1. doi:10.1016/j.eururo.2016.06.020:
  • Gschwend JE, Retz M, Kuebler H, et al. Indications and oncologic outcome of radical cystectomy for urothelial bladder cancer. Eur Urol Supplements. 2010;9(1):10–18.
  • Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–675.
  • Gschwend JE, Dahm P, Fair WR. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol. 2002;41(4):440–448.
  • Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21(4):690–696.
  • Lerner SP, Skinner DG, Lieskovsky G, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol. 1993;149(4):758–64; discussion 64-5.
  • Kaatsch P, Spix C, Katalinic A, et al. Krebs in Deutschland. Krebsbericht des Robert Koch Institut. 2012:1–156. doi:10.17886/rkipubl-2015-004.
  • World Health Organization Consensus Conference on Bladder C, Hautmann RE, Abol-Enein H, Hafez K, et al. Urinary diversion. Urology. 2007;69(1Suppl):17–49.
  • Witjes JA, Compérat E, Cowan NC, et al.EAU. Muscle-invasive and Metastatic Bladder Cancer. Eur Urol. 2016 Jun 30. pii: S0302-2838(16)30290-1. doi:10.1016/j.eururo.2016.06.020.
  • Menon M, Hemal AK, Tewari A, et al. Nerve sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int. 2003;92(3):232–236.
  • Shen Z, Sun Z. Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy. BMC Urol. 2016;16(1):59–63.
  • Hautmann RE, Stein JP. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am. 2005;32(2):177–185.
  • Kefer JC, Voelzke BB, Flanigan RC, et al. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology. 2005;66(6):1251–1255.
  • Pettus JA, Al-Ahmadie H, Barocas DA, et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol. 2008;53(2):370–375.
  • Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004;171(2 Pt 1):646–651.
  • Weizer AZ, Shah RB, Lee CT, et al. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy. Urol Oncol. 2007;25(6):460–464.
  • Damiano R, Di Lorenzo G, Cantiello F, et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur Urol. 2007;52(3):648–657.
  • Simone G, Papalia R, Leonardo C, et al. Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome. Urology 2008 Jul;72(1):162–166. doi:10.1016/j.urology.2007.11.077.
  • Remco R. de Vries, Jakko A. Nieuwenhuijzen, Harm van Tinteren, Prostate-sparing cystectomy: long term – oncological results. BJU Int. 2009;104:1239–1243.
  • Muto G, Collura D, Rosso R, et al. Seminal-sparing cystectomy: technical evolution and results over a 20-year period. Urology 2014 Apr;83(4):856–861. doi: 10.1016/j.urology.2013.08.093.
  • Basiri A, Pakmanesh H, Tabibi A, et al. Overall survival and functional results of prostate-sparing cystectomy: a matched case-control study. Urol J. 2012 Fall;9(4):678–684.
  • Vallancien G, Abou El, Fettouh H, et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol. 2002 Dec;168(6):2413–2417.
  • Mertens LS, Meijer RP, de Vries RR, et al. Prostate sparing cystectomy for bladder cancer: 20-year single center experience. J Urol. 2014 May;191(5):1250–1255. doi: 10.1016/j.juro.2013.11.031.
  • Saidi A, Nahon O, Daniel L, et al. Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases. Prog Urol. 2004 Apr;14(2):172–177; discussion 176. French.
  • Terrone C, Cracco C, Scarpa RM, et al. Supra-ampullar cystectomy with preservation of sexual function and ileal orthotopic reservoir for bladder tumor: twenty years of experience. Eur Urol. 2004 Aug;46(2):264–269; discussion 269–270.
  • Ozbir S, Girgin C, Kara C, et al. Local and systemic recurrence patterns of urothelial cancer after radical cystectomy. Kaohsiung J Med Sci. 2014;30(10):504–509.
  • Mitra AP, Quinn DI, Dorff TB, et al. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012;109(6):846–854.
  • Ide H, Kikuchi E, Miyajima A, et al. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer. Jpn J Clin Oncol. 2008;38(5):360–364.
  • Greven KM, Spera JA, Solin LJ, et al. Local recurrence after cystectomy alone for bladder carcinoma. Cancer. 1992;69(11):2767–2770.
  • Schoenberg MP, Walsh PC, Breazeale DR, et al. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol. 1996;155(2):490–494.
  • Westney OL, Pisters LL, Pettaway CA, et al. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1998;159(3):792–795.
  • Pisters LL, Westney L. The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol. 1996;14(2):112–119.
  • Freeman JA, Tarter TA, Esrig D, et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol. 1996;156(5):1615–1619.
  • Lebret T, Herve JM, Barre P, et al. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol. 1998;33(2):170–174.
  • Stein JP, Esrig D, Freeman JA, et al. Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. Urology. 1998;51(6):951–955.
  • Stein JP, Penson DF, Wu SD, et al. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J Urol. 2007;178(3 Pt 1):756–760.
  • Dotan ZA, Kavanagh K, Yossepowitch O, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol. 2007;178(6):2308–12; discussion 13.
  • Hadjizacharia P, Stein JP, Cai J, et al. The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer. World J Urol. 2009;27(1):33–38.
  • Neuzillet Y, Soulie M, Larre S, et al. Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study. BJU Int. 2013;111(8):1253–1260.
  • Alemozaffar M, Filson CP, Master VA. The importance of surgical margins in renal cell and urethelial carcinoma. J Surg Oncol. 2016;113:316–322.
  • Kim HS, Moon KC, Jeong CW, et al. The clinical significance of intraoperative ureteral frozen section analysis at radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2015 Mar;33(3):359–365.
  • Schumacher MC, Studer UE. Ureteric frozen section during radical cystectomy for TCC of the bladder, to do or not to do. BJU Int. 2008;103:1149–1159.
  • Herr HW, Faulkner JR, Grossmann HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781–2789.
  • Dotan ZA, Kavanagh K, Yossepowith O, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol. 2007;178:2308–2313.
  • Novara G, Svatek RS, Karakiewicz PI, et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010;183:2165–2170.
  • Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44(2):265–272.
  • Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303.
  • Marin F, Plesca M, Bordea CI, et al. Types of radical hysterectomies: from Thoma Ionescu and Wertheim to present day. J Med Life. 2014;7(2):172–176.
  • Hockel M. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology. Gynecol Oncol. 2007;107(1 Suppl 1):S106–12.
  • Stewart DB, Dietz DW. Total mesorectal excision: what are we doing? Clin Colon Rectal Surg. 2007;20(3):190–202.
  • Sundi D, Svatek RS, Nielsen ME, et al. Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? Rev Urol. 2014;16(4):159–166.
  • Witjes (Chair) JA, Compérat E, Cowan NC, et al. EAU guidelines: muscle-invasive and metastatic bladder cancer. EAU guidelines. 2015.
  • Whitmore WF Jr., Marshall VF. Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol. 1962;87:853–868.
  • Herr HW. Extent of pelvic lymph node dissection during radical cystectomy: where and why! Eur Urol. 2010;57(2):212–213.
  • Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160(6 Pt 1):2015–9; discussion 20.
  • Stein JP, Cai J, Groshen S, et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170(1):35–41.
  • Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol. 2007;178(4 Pt 1):1218–23; discussion 23-4.
  • Leissner J, Ghoneim MA, Abol-Enein H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171(1):139–144.
  • Herr HW, Smith JA, Montie JE. Standardization of radical cystectomy: time to count and be counted. BJU Int. 2004;94(4):481–482.
  • Koppie TM, Vickers AJ, Vora K, et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer. 2006;107(10):2368–2374.
  • Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol. 2001;166(6):2295–2296.
  • Bladder Cancer Collaborative G, Herr H, Lee C, Chang S, et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol. 2004;171(5):1823–1828.
  • Meijer RP, Nunnink CJ, Wassenaar AE, et al. Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes. J Urol. 2012;187(2):446–450.
  • Morgan TM, Kaffenberger SD, Cookson MS. Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol. 2012;188(4):1081–1088.
  • Parkash V, Bifulco C, Feinn R, et al. To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. Am J Clin Pathol. 2010;134(1):42–49.
  • Dhar NB, Klein EA, Reuther AM, et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008;179(3):873–8; discussion 8.
  • Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10(11):1053–1062.
  • Kurahashi T, Hara I, Oka N, et al. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res. 2005;11(10):3773–3777.
  • Marin-Aguilera M, Mengual L, Burset M, et al. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol. 2008;54(6):1363–1372.
  • Horn LC, Beckmann MW, Follmann M, et al. AWMF. S3-Leitlinie Diagnostik und Therapie Zervixkarzinom. Der Pathologe. 2015 Nov;36(6):5852–593. PMID:26483249.
  • Brossner C, Pycha A, Toth A, et al. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int. 2004;93(1):64–66.
  • Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–462.
  • Leissner J, Hohenfellner R, Thuroff JW, et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000;85(7):817–823.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.